Strain Information | |
---|---|
Image | ![]() |
BRC No. | RBRC00169 |
Type | Targeted Mutation Congenic![]() |
Species | Mus musculus |
Strain name | B6.Cg-Tnc<tm1Sia>/Rbrc |
Former Common name | C57BL/6N-TgH(Tnc), B6-TN, TNKO |
H-2 Haplotype | |
ES Cell line | TT2 [(C57BL/6NCrlj x CBA/JNCrlj)F1] |
Background strain | C57BL/6NJcl |
Appearance | black [a/a, B/B, C/C] |
Strain development | Saga Y et al. (1992)により作成されたテネイシン欠損マウスを元に開発されたテネイシン欠損コンジェニック系統の一つ。 |
Strain description | 細胞外基質テネイシンの機能解析のためのテネシイン欠損マウス系統。C57BL/6NJcl系統は代表的な近交系。B6/NはB6/J よりも繁殖性が良好。創傷治癒の機構解析。細胞接着、細胞間相互作用。毛色は黒。 |
Colony maintenance | Tnc(-/-)同士の兄妹交配。繁殖効率はA。実験群作出にはB6/N との交配必要。繁殖効率はB. |
References | Murine tenascin: cDNA cloning, structure and temporal expression of isoforms. Saga Y, Tsukamoto T, Jing N, Kusakabe M, Sakakura T Gene, 104, 177-185 (1991). 1717349Mice develop normally without tenascin. Saga Y, Yagi T, Ikawa Y, Sakakura T, Aizawa S Genes Dev., 6, 1821-1831 (1992). 1383086Can tenascin be redundant in cancer development? Sakakura T, Kusakabe M Perspect. Dev. Neurobiol., 2, 111-116 (1994). 7530137Tenascin knockout mice: barrels, boundary molecules, and glial scars. Steindler D A, Settles D, Erickson H P, Laywell E D, Yoshiki A, Faissner A, Kusakabe M J. Neurosci., 15, 1971-1983 (1995). 7534342Abnormal behavior and neurotransmissions of tenascin gene knockout mouse. Fukamauchi F, Mataga N, Wang Y J, Sato S, Youshiki A, Kusakabe M Biochem. Biophys. Res. Commun., 221, 151-156 (1996). 8660327Tyrosine hydroxylase activity and its mRNA level in dopaminergic neurons of tenascin gene knockout mouse. Fukamauchi F, Mataga N, Wang Y J, Sato S, Yoshiki A, Kusakabe M Biochem. Biophys. Res. Commun., 231, 356-359 (1997). 9070278Tenascin-C promotes healing of Habu-snake venom-induced glomerulonephritis: studies in knockout congenic mice and in culture. Nakao N, Hiraiwa N, Yoshiki A, Ike F, Kusakabe M Am. J. Pathol., 152, 1237-1245 (1998). 9588892Effect of tenascin-C deficiency on chemically induced dermatitis in the mouse. Koyama Y, Kusubata M, Yoshiki A, Hiraiwa N, Ohashi T, Irie S, Kusakabe M J. Invest. Dermatol., 111, 930-935 (1998). 9856798Corneal wound healing in tenascin knockout mouse. Matsuda A, Yoshiki A, Tagawa Y, Matsuda H, Kusakabe M Invest. Ophthalmol. Visual. Sci., 40, 1071-1080 (1999). 10235540Loss of cortical and thalamic neuronal tenascin-C expression in a transgenic mouse expressing exon 1 of the human Huntington disease gene. Kusakabe M, Mangiarini L, Laywell E D, Bates G P, Yoshiki A, Hiraiwa N, Inoue J, Steindler D A J. Comp. Neurol., 430, 485-500 (2001). 11169482more 3 referencesPDGF receptor-alpha deficiency in glomerular mesangial cells of tenascin-C knockout mice. Matsumoto K, Hiraiwa N, Yoshiki A, Ohnishi M, Kusakabe M Biochem. Biophys. Res. Commun., 290, 1220-1227 (2002). 11811993Invasion of melanoma in double knockout mice lacking tenascin-X and tenascin-C. Matsumoto K, Takahashi K, Yoshiki A, Kusakabe M, Ariga H Jpn. J. Cancer Res., 93, 968-975 (2002). 12359049Tenascin-C expression and splice variant in habu snake venom-induced glomerulonephritis. Matsumoto K, Hiraiwa N, Yoshiki A, Ohnishi M, Kusakabe M Exp. Mol. Pathol., 72, 186-195 (2002). 12009782 |
Health Report | |
---|---|
Examination Date / Room / Rack |
Gene | |||||||
---|---|---|---|---|---|---|---|
Gene Symbol | Gene Name | Chr. | Allele Symbol | Allele Name | Common Names | Promoter | Diseases Related to This Gene |
Tnc MGI:101922 | tenascin C | 4 | Tnc<tm1Sia> MGI:2148540 | targeted mutation 1, Shinichi Aizawa | |||
lacZ | beta-galactosidase (E. coli) | 4 | |||||
neo | neomycin resistance gene (E. coli) | 4 | mouse phosphoglycerate kinase promoter (PGK promoter) |
Phenotype | |
---|---|
Phenotype annotation from literatures by Mammalian phenotype ontology | more 3 phenotypes |
Detailed phenotype data |
Ordering Information | |
---|---|
供与核酸 | E. coli lacZ, mouse phosphoglycerate kinase promoter (PGK promoter), E. coli neo, mouse tenascin genomic DNA |
Research application | Neurobiology Research |
提供条件 | 研究成果の公表にあたって寄託者の指定する文献を引用する。Am. J. Pathol., 152, 1237-1245 (1998). J. Invest. Dermatol., 111, 930-935 (1998). Invest. Ophthalmol. Visual. Sci., 1071-1080 (1999). |
Depositor | RIKEN BRC(独立行政法人理化学研究所) |
Strain Status | ![]() ![]() |
Strain Availability | 凍結胚より作出したマウスを2~4ヶ月以内に提供可能 凍結精子を1ヶ月以内に提供可能 凍結胚を1ヶ月以内に提供可能 |
Additional Info. | Necessary documents for ordering:
Genotyping protocol -PCR- |
BRC mice in Publications |
---|
Yonemura A, Semba T, Zhang J, Fan Y, Yasuda-Yoshihara N, Wang H, Uchihara T, Yasuda T, Nishimura A, Fu L, Hu X, Wei F, Kitamura F, Akiyama T, Yamashita K, Eto K, Iwagami S, Iwatsuki M, Miyamoto Y, Matsusaki K, Yamasaki J, Nagano O, Saya H, Song S, Tan P, Baba H, Ajani JA, Ishimoto T. Mesothelial cells with mesenchymal features enhance peritoneal dissemination by forming a protumorigenic microenvironment. Cell Rep 43(1) 113613(2024) 38232734 |
Moriyama M, Nakamura K, Nagata H, Wada I, Nagira K, Azuma Y, Sato E, Harada T, Taniguchi F. Role of tenascin C in lesion formation in early peritoneal endometriosis. F S Sci 5(1) 69-79(2024) 38092313 |
Tashjian RZ, Zitnay J, Kazmers NH, Veerabhadraiah SR, Zelada AC, Honeggar M, Smith MC, Chalmers PN, Henninger HB, Jurynec MJ. Tenascin C deletion impairs tendon healing and functional recovery after rotator cuff repair. J Orthop Res (2024) 39601211 |
Xu M, Ye Z, Zhao X, Guo H, Gong X, Huang R. Deficiency of tenascin-C attenuated cardiac injury by inactivating TLR4/NLRP3/caspase-1 pathway after myocardial infarction. Cell Signal 86 110084(2021) 34271086 |
Kubo Y, Ishikawa K, Mori K, Kobayashi Y, Nakama T, Arima M, Nakao S, Hisatomi T, Haruta M, Sonoda KH, Yoshida S. Periostin and tenascin-C interaction promotes angiogenesis in ischemic proliferative retinopathy. Sci Rep 10(1) 9299(2020) 32518264 |
Ito K, Morimoto J, Kihara A, Matsui Y, Kurotaki D, Kanayama M, Simmons S, Ishii M, Sheppard D, Takaoka A, Uede T. Integrin α9 on lymphatic endothelial cells regulates lymphocyte egress. Proc Natl Acad Sci U S A 111(8) 3080-5(2014) 24516133 |
Nakamura-Ishizu A, Okuno Y, Omatsu Y, Okabe K, Morimoto J, Uede T, Nagasawa T, Suda T, Kubota Y. Extracellular matrix protein tenascin-C is required in the bone marrow microenvironment primed for hematopoietic regeneration. Blood 119(23) 5429-37(2012) 22553313 |
Imanaka-Yoshida K, Matsumoto K, Hara M, Sakakura T, Yoshida T. The dynamic expression of tenascin-C and tenascin-X during early heart development in the mouse. Differentiation 71(4-5) 291-8(2003) 12823230 |
Matsumoto K, Takahashi K, Yoshiki A, Kusakabe M, Ariga H. Invasion of melanoma in double knockout mice lacking tenascin-X and tenascin-C. Jpn J Cancer Res 93(9) 968-75(2002) 12359049 |